Actively Recruiting
A Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic Cardiomyopathy
Led by Shandong Suncadia Medicine Co., Ltd. · Updated on 2025-09-10
300
Participants Needed
1
Research Sites
125 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study mainly evaluates the long-term safety of HRS-1893 in subjects with hypertrophic cardiomyopathy.
CONDITIONS
Official Title
A Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic Cardiomyopathy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 to 85 years with hypertrophic cardiomyopathy who have previously completed HRS-1893 studies
- Female participants of childbearing potential must have a negative serum pregnancy test within 7 days before the first dose and must not be breastfeeding during the study
- Female participants of childbearing potential and male participants with partners of childbearing potential must agree to avoid donating sperm or eggs from consent until 3 months after the last dose and follow contraceptive guidelines
- Ability to understand study procedures and voluntarily sign informed consent
You will not qualify if you...
- History of coronary artery disease with one or more arteries narrowed by more than 70% or history of heart attack
- Use of negative inotropic medications other than disopyramide, beta-blockers, verapamil, or diltiazem within 4 weeks before screening
- History of fainting or sustained ventricular tachycardia within 6 months before screening
- Any physical or psychological condition that the investigator judges unsuitable for participation, including increased risk, poor compliance, or inability to complete the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Beijing, Beijing Municipality, China, 100037
Actively Recruiting
Research Team
J
Jianhong Lv
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here